Los resultados secundarios incluyeron el cambio en el peso corporal desde el inicio hasta el final del seguimiento (36 meses), el cambio en la A1c y el peso corporal en subgrupos de pacientes que estaban en tratamiento de forma persistente (a los 12, 24, 36 meses), y el cambio en la hemoglobina glicosilada A1c y el peso corporal en subgrupos estratificados por caractersticas iniciales
Professional Medical Disclaimer: If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering prescription weight management treatment, consult your physician before starting any new treatment
Most effective when used consistently (3-4 times per week)
Documenting which joints are affected, the timing of symptoms relative to tirzepatide dosing, and any associated features such as swelling, redness, or morning stiffness helps differentiate mechanical joint pain from inflammatory conditions requiring different management approaches